Search results
Down 44.4% in 4 Weeks, Here's Why Infinity (INFI) Looks Ripe for a Turnaround
Zacks via Yahoo Finance· 2 years agoThe heavy selling pressure might have exhausted for Infinity (INFI) as it is technically in oversold...
Infinity Pharma (INFI) Stock Up on Advancing Cancer Study
Zacks via Yahoo Finance· 12 months agoInfinity Pharma (INFI) provides insights on the phase II MARIO-8 study design. The study will...
Infinity Pharmaceuticals (INFI) Reports Q3 Loss, Lags Revenue Estimates
Zacks via Yahoo Finance· 2 years agoInfinity (INFI) delivered earnings and revenue surprises of -140% and 91.23%, respectively, for the...
Investors in Infinity Pharmaceuticals (NASDAQ:INFI) have unfortunately lost 58% over the last year
Simply Wall St. via Yahoo Finance· 2 years agoIt is doubtless a positive to see that the Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) share price...
How Many Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) Shares Do Institutions Own?
Simply Wall St. via Yahoo Finance· 2 years agoEvery investor in Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) should be aware of the most powerful...
A number of insiders bought Infinitum Copper Corp. (CVE:INFI) stock last year, which is great news...
Simply Wall St. via Yahoo Finance· 1 year agoWhen a single insider purchases stock, it is typically not a major deal. However, when multiple...
The past five years for Infinity Pharmaceuticals (NASDAQ:INFI) investors has not been profitable
Simply Wall St. via Yahoo Finance· 1 year agoStatistically speaking, long term investing is a profitable endeavour. But along the way some stocks...
Will Infinity Pharmaceuticals (INFI) Report Negative Q4 Earnings? What You Should Know
Zacks via Yahoo Finance· 1 year agoInfinity (INFI) doesn't possess the right combination of the two key ingredients for a likely...
Infinity Pharmaceuticals Third Quarter 2022 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 2 years agoInfinity Pharmaceuticals (NASDAQ:INFI) Third Quarter 2022 Results Key Financial Results Net loss:...
Infinity Pharma Posts 52% Increase In One-Year Progression Free Survival Rate In Breast Cancer...
Benzinga via Yahoo Finance· 2 years agoInfinity Pharmaceuticals Inc (NASDAQ: INFI) reported an update from its MARIO-3 study of eganelisib...